• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

CGI Pharmaceuticals

edit

CGI Pharmaceuticals, Inc., a development-stage pharmaceutical company, discovers and develops small molecule therapeutics for multiple oncology and immunology-based indications. The company provides drug discovery and development programs, including Btk, a B-cell kinase for a range of AAID and oncology indications; and Syk, a regulator of mast cell, monocyte/macrophage, and B-cell functions. CGI Pharmaceuticals, Inc. was founded in 2000 as Cellular Genomics, Inc. and changed its name to CGI Pharmaceuticals, Inc. in September, 2005. The company is headquartered in Branford, Connecticut.

Recent Milestones

edit

• 
  CGI Pharmaceuticals was acquired by Gilead Sciences for $120M. (6/25/10)
  Posted 6/25/10 at 7:05pm via fiercebiotech.com
• 
  CGI Pharmaceuticals added Peter Fuller as COO.
  Posted 6/25/10 at 7:02pm
• 
  CGI Pharmaceuticals added Muzammil Mansuri as Executive Chairman & CEO.
  Posted 6/25/10 at 7:02pm
• 
  CGI Pharmaceuticals added David Armistead as CSO.
  Posted 6/25/10 at 7:02pm

Videos

Screenshots

edit

Sources

1. Gilead to buy CGI Pharm for $120M (fiercebiotech.com) [edit]